Emerging antimicrobial-resistant infections

Archives of Neurology

Volumn 61, Issue 10, 2004, Pages 1512-1514

  Roos, Karen L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD DISEASE; CATHETERIZATION; CENTRAL NERVOUS SYSTEM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMBINATION CHEMOTHERAPY; CRANIOTOMY; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG TOLERANCE; DRUG USE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FEVER; GASTROINTESTINAL DISEASE; GRAM NEGATIVE BACTERIUM; HEADACHE; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RESISTANCE; LONG TERM CARE; MENTAL DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NEUROSURGERY; PENICILLIN RESISTANCE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; STRONGYLOIDES; TINNITUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; HUMANS; UNITED STATES; VANCOMYCIN;

EID: 5344246631     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.10.1512     Document Type: Review

References (23)

1. Kaplan SL, Mason EO. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002;31:250-260.
2. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-139.
3. Cosgrove SE, Sakouias G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53-59.
4. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51: 565-567.
5. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptiblity Testing, Tenth Informational Supplement (Aerobic Dilution). Wayne, Pa: National Committee for Clinical Laboratory Standards; 2000.
6. Jacobs MR. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am J Med. 1999;106:19S-25S.
7. Bonafede M, Rice LB. Emerging antibiotic resistance. J Lab Clin Med. 1997;130: 558-566.
8. McCullers JA, English BK, Novack R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis. 2000;181:369-373.
9. Novack R, Henriques B, Charpentier E, Normark S, Toumanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature. 1999;399:590-593.
10. Liu HH, Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis. 1985;152:365-372.
11. Paterson DL, Rice LB. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis. 2003;36:1006-1012.
12. Greenlee JE, Carroll KC. Cerebrospinal fluid in CNS infections. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1997:899-922.
13. Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev. 1992;5:130-145.
14. Nathan BR, Scheld WM. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. In: Remington JS, Schwartz MN, eds. Current Clinical Topics in Infectious Diseases. Vol 22. Oxford, England: Blackwell Science Ltd; 2002: 155-165.
15. Bartlett JG, Bradley SF, Herwaldt LA, Jacobs MR, Perl TM, Poole MD. A roundtable discussion of antibiotic resistance: putting lessons to work. Am J Med. 1999; 106:49S-52S.
16. Chang S, Sievert DM, Hageman JC, Boulton ML. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347.
17. Wen DY, Bottini AG, Hall WA, Haines SJ. The intraventricular use of antibiotics. Neurosurg Clin N Am. 1992;3:343.
18. Golledge CL, McKenzie T. Monitoring vancomycin concentrations in CSF after intraventricular administration. J Antimicrob Chemother. 1988;21:262.
19. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
20. Zeana C, Kubin CJ, Della-Latta P, Hammer SM. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature. Clin Infect Dis. 2001;33:477-482.
21. Steinmetz MP, Vogelbaum MA, De Georgia MA, Andrefsky JC, Isada C. Successful treatment of vancomycin-resistant enterococcus meningitis with linezolid: case report and review of the literature. Crit Care Med. 2001;29:2383-2385.
22. Zurenko JE, Todd WM, Hafkin B, et al. Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid. In: Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, Calif. Washington, DC: American Society for Microbiology; 1999:117. Abstract 848.
23. Williamson JC, Glazier FS, Peacock JE. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg. 2002; 104:54-56.